Pharminent

Charles River strategic partnership to populate R&D pipeline, shorten timelines

As part of the company’s continued growth, Charles River’s recent partnership with The Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) will work to accelerate drug development. http://www.outsourcing-pharma.com/Preclinical-Research/Charles-River-strategic-partnership-with-Tri-I-TDI

Filed under: R&D